{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T01:57:39Z","timestamp":1762999059707},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,5,7]],"date-time":"2014-05-07T00:00:00Z","timestamp":1399420800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2458-14-433","type":"journal-article","created":{"date-parts":[[2014,5,7]],"date-time":"2014-05-07T19:02:21Z","timestamp":1399489341000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["A pragmatic, randomized, controlled study evaluating the impact of access to smoking cessation pharmacotherapy coverage on the proportion of successful quitters in a Canadian population of smokers motivated to quit (ACCESSATION)"],"prefix":"10.1186","volume":"14","author":[{"given":"Peter","family":"Selby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Brosky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Arteaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Ranger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,7]]},"reference":[{"key":"6572_CR1","volume-title":"WHO REPORT on the Global Tobacco Epidemic","author":"World Health Organization","year":"2008","unstructured":"World Health Organization: WHO REPORT on the Global Tobacco Epidemic. 2008, The MPOWER package [ http:\/\/www.who.int\/tobacco\/mpower\/mpower_report_full_2008.pdf ], . The MPOWER package"},{"key":"6572_CR2","volume-title":"Cochrane Database Syst Rev","author":"LF Stead","year":"2008","unstructured":"Stead LF, Perera R, Bullen C, Mant D, Lancaster T: Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008, 1: CD000146"},{"key":"6572_CR3","volume-title":"Cochrane Database Syst Rev","author":"JR Hughes","year":"2007","unstructured":"Hughes JR, Stead LF, Lancaster T: Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2007, 1: CD000031"},{"key":"6572_CR4","volume-title":"Cochrane Database Syst Rev","author":"K Cahill","year":"2012","unstructured":"Cahill K, Stead LF, Lancaster T: Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2012, 4: CD006103"},{"key":"6572_CR5","unstructured":"Tran K, Asakawa K, Cimon K, Moulton K, Kaunelis D, Pipe A, Selby P: Pharmacologic-based strategies for Smoking Cessation: Clinical and Cost-effectiveness Analyses. [ http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3442619\/ ]"},{"issue":"2","key":"6572_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1503\/cmaj.070256","volume":"179","author":"MJ Eisenberg","year":"2008","unstructured":"Eisenberg MJ, Filion KB, Yavin D, B\u00e9lisle P, Mottillo S, Joseph L, Gervais A, O'Loughlin J, Paradis G, Rinfret S, Pilote L: Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. CMAJ. 2008, 179 (2): 135-144. 10.1503\/cmaj.070256.","journal-title":"CMAJ"},{"issue":"11","key":"6572_CR7","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1503\/cmaj.070627","volume":"177","author":"B Le Foll","year":"2007","unstructured":"Le Foll B, George TP: Treatment of tobacco dependence: integrating recent progress into practice. CMAJ. 2007, 177 (11): 1373-1380. 10.1503\/cmaj.070627.","journal-title":"CMAJ"},{"issue":"18","key":"6572_CR8","doi-asserted-by":"publisher","first-page":"E810","DOI":"10.1503\/cmaj.101140","volume":"182","author":"ED Penz","year":"2010","unstructured":"Penz ED, Manns BJ, H\u00e9bert PC, Stanbrook MB: Governments, pay for smoking cessation. CMAJ. 2010, 182 (18): E810-10.1503\/cmaj.101140.","journal-title":"CMAJ"},{"key":"6572_CR9","volume-title":"Cochrane Database Syst Rev","author":"AA Reda","year":"2012","unstructured":"Reda AA, Kotz D, Evers SM, van Schayck CP: Healthcare financing systems for increasing the use of tobacco dependence treatment. Cochrane Database Syst Rev. 2012, 6: CD004305"},{"issue":"5","key":"6572_CR10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/tc.2010.038703","volume":"20","author":"Y Le Strat","year":"2011","unstructured":"Le Strat Y, Rehm J, Le Foll B: How generalisable to community samples are clinical trial results for treatment of nicotine dependence: a comparison of common eligibility criteria with respondents of a large representative general population survey. Tob Control. 2011, 20 (5): 338-343. 10.1136\/tc.2010.038703.","journal-title":"Tob Control"},{"key":"6572_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/1471-2288-12-101","volume":"12","author":"P Selby","year":"2012","unstructured":"Selby P, Brosky G, Oh P, Raymond V, Ranger S: How pragmatic or explanatory is the randomized, controlled trial? The application and enhancement of the PRECIS tool to the evaluation of a smoking cessation trial. BMC Med Res Methodol. 2012, 12: 101-10.1186\/1471-2288-12-101.","journal-title":"BMC Med Res Methodol"},{"issue":"10","key":"6572_CR12","doi-asserted-by":"publisher","first-page":"E47","DOI":"10.1503\/cmaj.090523","volume":"180","author":"KE Thorpe","year":"2009","unstructured":"Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG, Tunis S, Bergel E, Harvey I, Magid DJ, Chalkidou K: A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. CMAJ. 2009, 180 (10): E47-E57. 10.1503\/cmaj.090523.","journal-title":"CMAJ"},{"issue":"11","key":"6572_CR13","first-page":"763","volume":"69","author":"KO Fagerstrom","year":"1990","unstructured":"Fagerstrom KO, Heatherton TF, Kozlowski LT: Nicotine addiction and its assessment. Ear Nose Throat J. 1990, 69 (11): 763-765.","journal-title":"Ear Nose Throat J"},{"issue":"9","key":"6572_CR14","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","volume":"86","author":"TF Heatherton","year":"1991","unstructured":"Heatherton TF, Kozlowski LT, Frecker RC, Fagerstr\u00f6m KO: The Fagerstr\u00f6m Test for Nicotine Dependence: a revision of the Fagerstr\u00f6m Tolerance Questionnaire. Br J Addict. 1991, 86 (9): 1119-1127. 10.1111\/j.1360-0443.1991.tb01879.x.","journal-title":"Br J Addict"},{"issue":"7","key":"6572_CR15","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1176\/ajp.2007.164.7.1035","volume":"164","author":"K Posner","year":"2007","unstructured":"Posner K, Oquendo MA, Gould M, Stanley B, Davies M: Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. A J Psychiatry. 2007, 164 (7): 1035-1043. 10.1176\/appi.ajp.164.7.1035.","journal-title":"A J Psychiatry"},{"key":"6572_CR16","volume-title":"Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline","author":"FC Fiore","year":"2008","unstructured":"Fiore FC, Ja\u00e9n CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ: Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. 2008, Rockville, MD: U.S. Department of Health and Human Services Public Health Service"},{"issue":"1","key":"6572_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/1462220031000070552","volume":"5","author":"JR Hughes","year":"2003","unstructured":"Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE: Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res. 2003, 5 (1): 13-25. 10.1093\/ntr\/5.1.13.","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"6572_CR18","first-page":"47","volume":"23","author":"SL Wong","year":"2012","unstructured":"Wong SL, Shields M, Leatherdale S, Malaison E, Hammond D: Assessment of validity of self-reported smoking status. Health Rep. 2012, 23 (1): 47-53.","journal-title":"Health Rep"},{"issue":"1","key":"6572_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jama.296.1.47","volume":"296","author":"D Gonzales","year":"2006","unstructured":"Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR: Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA. 2006, 296 (1): 47-55. 10.1001\/jama.296.1.47.","journal-title":"JAMA"},{"issue":"1","key":"6572_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1001\/jama.296.1.56","volume":"296","author":"DE Jorenby","year":"2006","unstructured":"Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR: Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA. 2006, 296 (1): 56-63. 10.1001\/jama.296.1.56.","journal-title":"JAMA"},{"key":"6572_CR21","volume-title":"Cochrane Database Syst Rev","author":"J Kaper","year":"2005","unstructured":"Kaper J, Wagena EJ, Severens JL, Van Schayck CP: Healthcare financing systems for increasing the use of tobacco dependence treatment. Cochrane Database Syst Rev. 2005, 1: CD004305"},{"issue":"11","key":"6572_CR22","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1111\/j.1360-0443.2006.01578.x","volume":"101","author":"J Kaper","year":"2006","unstructured":"Kaper J, Wagena EJ, Willemsen MC, van Schayck CP: A randomized controlled trial to assess the effects of reimbursing the costs of smoking cessation therapy on sustained abstinence. Addiction. 2006, 101 (11): 1656-1661. 10.1111\/j.1360-0443.2006.01578.x.","journal-title":"Addiction"},{"issue":"1","key":"6572_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1360-0443.2004.00540.x","volume":"99","author":"JR Hughes","year":"2004","unstructured":"Hughes JR, Keely J, Naud S: Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004, 99 (1): 29-38. 10.1111\/j.1360-0443.2004.00540.x.","journal-title":"Addiction"},{"issue":"7","key":"6572_CR24","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1111\/j.1360-0443.2005.01097.x","volume":"100","author":"J Kaper","year":"2005","unstructured":"Kaper J, Wagena EJ, Willemsen MC, van Schayck CP: Reimbursement for smoking cessation treatment may double the abstinence rate: results of a randomized trial. Addiction. 2005, 100 (7): 1012-1020. 10.1111\/j.1360-0443.2005.01097.x.","journal-title":"Addiction"},{"issue":"4","key":"6572_CR25","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1360-0443.2007.01750.x","volume":"102","author":"R West","year":"2007","unstructured":"West R: The clinical significance of \"small\" effects of smoking cessation treatments. Addiction. 2007, 102 (4): 506-509.","journal-title":"Addiction"},{"key":"6572_CR26","doi-asserted-by":"publisher","first-page":"a2390","DOI":"10.1136\/bmj.a2390","volume":"337","author":"M Zwarenstein","year":"2008","unstructured":"Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, Oxman AD, Moher D: Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008, 337: a2390-10.1136\/bmj.a2390.","journal-title":"BMJ"},{"issue":"2","key":"6572_CR27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1136\/tc.10.2.175","volume":"10","author":"HH Schauffler","year":"2001","unstructured":"Schauffler HH, McMenamin S, Olson K, Boyce-Smith G, Rideout JA, Kamil J: Variations in treatment benefits influence smoking cessation: results of a randomised controlled trial. Tob Control. 2001, 10 (2): 175-180. 10.1136\/tc.10.2.175.","journal-title":"Tob Control"},{"issue":"2","key":"6572_CR28","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s12160-010-9252-y","volume":"41","author":"TB Baker","year":"2011","unstructured":"Baker TB, Mermelstein R, Collins LM, Piper ME, Jorenby DE, Smith SS, Christiansen BA, Schlam TR, Cook JW, Fiore MC: New methods for tobacco dependence treatment research. Ann Behav Med. 2011, 41 (2): 192-207. 10.1007\/s12160-010-9252-y.","journal-title":"Ann Behav Med"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-14-433.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-14-433\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-14-433","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T01:03:18Z","timestamp":1468458198000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-14-433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["6572"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-14-433","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,7]]},"article-number":"433"}}